The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial

被引:0
|
作者
Sahar Foshati
Maryam Poursadeghfard
Zahra Heidari
Reza Amani
机构
[1] Shiraz University of Medical Sciences,Nutrition Research Center, Department of Clinical Nutrition, School of Nutrition and Food Sciences
[2] Shiraz University of Medical Sciences,Clinical Neurology Research Center
[3] Isfahan University of Medical Sciences,Department of Biostatistics and Epidemiology, School of Health
[4] Isfahan University of Medical Sciences,Department of Clinical Nutrition, School of Nutrition and Food Science
关键词
Abdominal pain; Bloating; Constipation; Ginger; Multiple sclerosis; Nausea;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Effects of adjunct glucosamine sulfate on relapsing-remitting multiple sclerosis progression: Preliminary findings of a randomized, placebo-controlled trial
    Shaygannejad, Vahid
    Janghorbani, Mohsen
    Savoj, Mohammad Reza
    Ashtari, Fereshteh
    NEUROLOGICAL RESEARCH, 2010, 32 (09) : 981 - 985
  • [32] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    DUQUETTE, P
    GIRARD, M
    DESPAULT, L
    DUBOIS, R
    KNOBLER, RL
    LUBLIN, FD
    KELLEY, L
    FRANCIS, GS
    LAPIERRE, Y
    ANTEL, J
    FREEDMAN, M
    HUM, S
    GREENSTEIN, JI
    MISHRA, B
    MULDOON, J
    WHITAKER, JN
    EVANS, BK
    LAYTON, B
    SIBLEY, WA
    LAGUNA, J
    KRIKAWA, J
    PATY, DW
    OGER, JJ
    KASTRUKOFF, LF
    MOORE, GRW
    HASHIMOTO, SA
    MORRISON, W
    NELSON, J
    GOODIN, DS
    MASSA, SM
    GUTTERIDGE, E
    ARNASON, BGW
    NORONHA, A
    REDER, AT
    MARTIA, R
    EBERS, GC
    RICE, GPA
    LESAUX, J
    JOHNSON, KP
    PANITCH, HS
    BEVER, CT
    CONWAY, K
    WALLENBERG, JC
    BEDELL, L
    VANDENNOORT, S
    WEINSHENKER, B
    WEISS, W
    REINGOLD, S
    PACHNER, A
    TAYLOR, W
    NEUROLOGY, 1993, 43 (04) : 655 - 661
  • [33] Interferon beta-1b is effective in relapsing-remitting multiple sclerosis I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
    Sibley, WA
    NEUROLOGY, 2001, 57 (12) : S3 - S9
  • [34] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
    Ebers, GC
    Rice, G
    Lesaux, J
    Paty, D
    Oger, J
    Li, DKB
    Beall, S
    Devonshire, V
    Hashimoto, S
    Hooge, J
    Kastrukoff, L
    Krieger, C
    Mezei, M
    Seland, P
    Vorobeychi, G
    Morrison, W
    Nelson, J
    Freedman, MS
    Chrisie, S
    Nelson, R
    Rabinovitch, H
    Freedman, C
    Hartung, HP
    Rieckmann, P
    Archelos, J
    Jung, S
    Weilbach, F
    Flachenecke, P
    Sauer, J
    Hommes, O
    Jongen, P
    Brouwer, S
    McLeod, J
    Pollard, J
    Ng, R
    Sandberg-Wollheim, M
    Källén, K
    Nilsson, P
    Ekberg, R
    Lundgren, A
    Jadbäck, G
    Wikström, J
    Multanen, J
    Valjakka, M
    Carton, H
    Lissoir, F
    Declerq, I
    Vieren, M
    Peeters, E
    Dubois, B
    LANCET, 1998, 352 (9139): : 1498 - 1504
  • [35] Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
    Kappos, Ludwig
    Gold, Ralf
    Miller, David H.
    MacManus, David G.
    Havrdova, Eva
    Limmroth, Volker
    Polman, Chris H.
    Schmierer, Klaus
    Yousry, Tarek A.
    Yang, Minhua
    Eraksoy, Mefkure
    Meluzinova, Eva
    Rektor, Ivan
    Dawson, Katherine T.
    Sandrock, Alfred W.
    O'Neill, Gilmore N.
    LANCET, 2008, 372 (9648): : 1463 - 1472
  • [36] Low dose interleukin-2 in relapsing-remitting multiple sclerosis: A randomized double-blinded placebo-controlled trial
    Louapre, C.
    Rosenzwag, M.
    Golse, M.
    Galanaud, D.
    Papeix, C.
    Maillart, E.
    Ungureanu, A.
    Corvol, J. -C.
    Vicaut, E.
    Lubetzki, C.
    Klatzmann, D.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 550 - 551
  • [37] Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study
    J. C. Bertoglio
    M. Baumgartner
    R. Palma
    E. Ciampi
    C. Carcamo
    D. D. Cáceres
    G. Acosta-Jamett
    J. L. Hancke
    R. A. Burgos
    BMC Neurology, 16
  • [38] Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study
    Bertoglio, J. C.
    Baumgartner, M.
    Palma, R.
    Ciampi, E.
    Carcamo, C.
    Caceres, D. D.
    Acosta-Jamett, G.
    Hancke, J. L.
    Burgos, R. A.
    BMC NEUROLOGY, 2016, 16
  • [39] Randomized, double-blind, placebo-controlled study of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis: a categorical disability trend analysis
    Liu, C
    Blumhardt, LD
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (01) : 10 - 14
  • [40] A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis
    Vollmer, Timothy L.
    Robinson, Michael J.
    Risser, Richard C.
    Malcolm, Sandra K.
    PAIN PRACTICE, 2014, 14 (08) : 732 - 744